SEC Form 4 · accession 0001209191-17-018818
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James A Geraghty
Director
Period of report
Mar 3, 2017
Accepted (ET)
Mar 7, 2017 · 5:06 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.15 | Mar 3, 2017 | A | 30,000 | A | — | Mar 3, 2024 | Common stock, $0.01 par value per share | 30,000 | 30,000 | D |
Explanation of responses
- F1This option will be exercisable as follows: 33.3% on the first two anniversaries of the grant date; and the final 33.4% on third anniversary of grant date.